H. J. KİM Et Al. , "Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study," Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum , 2020
KİM, H. J. Et Al. 2020. Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study. Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum .
KİM, H. J., PİTTOCK, S. J., BERTHELE, A., FUJİHARA, K., LEVY, M., PALACE, J., ... NAKASHİMA, I.(2020). Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study . Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum
KİM, H Et Al. "Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study," Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 2020
KİM, H J. Et Al. "Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study." Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum , 2020
KİM, H. J. Et Al. (2020) . "Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study." Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum .
@conferencepaper{conferencepaper, author={H J KİM Et Al. }, title={Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study}, congress name={Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum}, city={}, country={}, year={2020}}